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ABSTRACT
When presented alone, H7a and HY antigens elicit CD8 T-cell responses of similar amplitude, but H7a totally
abrogates the response to HY when both antigens are presented on the same antigen-presenting cell. We
found that H7a- and HY-specific T-cell precursors had similar frequencies in nonimmune mice and expressed
similar levels of CD5. The H7a-specific CD8 T-cell repertoire harvested at the time of primary response
showed highly restricted T-cell receptor (TCR) diversity. Furthermore, T cells specific for H7a and HY
expressed equivalent levels of CD8 and TCR and displayed similar tetramer decay rates. The key difference
was that anti-H7a T cells exhibited a much more rapid TCR:epitope on-rate than anti-HY T cells. Coupled
with evidence that primed CD8 T cells limit the duration of antigen presentation by killing or inactivating
antigen-presenting cells, our data support a novel and simple model for immunodomination: the main feature
of T cells that exert immunodomination is that, compared with other T cells, they are functionally primed after
a shorter duration of antigen presentation.
© 2005 American Society for Blood and Marrow Transplantation
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sNTRODUCTION
It is relatively easy to elicit CD8 T-cell responses
gainst an epitope presented alone on professional
ntigen-presenting cells (APCs), provided that anti-
en-reactive T cells are present in the T-cell reper-
oire. However, under most circumstances, such as
ith infection and transplantation, immune responses
re triggered by APCs that present a multitude of
onself epitopes. In this case, CD8 T cells respond to
nly a few immunodominant epitopes and neglect
ther potentially immunogenic peptides. Restriction
f CD8 T-cell responses to a few selected epitopes has
een termed immunodominance, a central and robust
eature of immune responses [1-8]. At face value, re-
tricting cytotoxic T lymphocyte (CTL) responses to
mmunodominant epitopes can be viewed as a low-
isk, high-efﬁciency strategy for the immune system:
imiting the diversity of the immune response mini- c
60izes the potential for autoimmune recognition, and
ocusing on the best epitopes confers good chances to
apidly eliminate pathogens [9,10].
The immunodominance hierarchy is largely dic-
ated by the immunodomination process whereby
ominant epitopes abrogate responses to nondomi-
ant epitopes [11]. Immunodomination results from
ross-competition between T cells speciﬁc for differ-
nt epitopes [12]. Studies based on adoptive transfer of
raded numbers of CD8 T cells speciﬁc for various
nﬂuenza peptides showed that the capacity to exert
and to resist) immunodomination varies considerably
ith the speciﬁcity of CD8 T cells and is a cause
ather than an effect of the immunodominance hier-
rchy [11]. In most models, immunodomination re-
ults from competition for APC resources among re-
ponding CD8 T cells, because it disappears when
ompeting epitopes are presented on different APCs
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Selection of Immunodominant Determinants
Br when APCs are present in large excess [3,13-17].
ccordingly, immunodomination is mitigated under
onditions in which antigen presentation is not limiting,
uch as lymphocytic choriomeningitis virus (LCMV) in-
ection [12,18].
The mechanisms of competition for APC re-
ources that lead to immunodomination remain ill
eﬁned. Many models suggest that the crux of immu-
odomination is APC killing [19,20]. However, at
east under certain conditions, immunodomination
an be driven by means other than APC destruction
12]. One attractive possibility would be that early
nteractions with CTLs speciﬁc for immunodominant
pitopes lead to functional exhaustion or inactivation
f APCs. Indeed, after activation, dendritic cells pro-
uce interleukin (IL)–12 only transiently and rapidly
ecome functionally exhausted [21]. It is interesting to
ote that secretion of interferon (IFN)-, which is
apidly produced at the CTL/APC interface, is instru-
ental in suppressing responses to nondominant
pitopes [17,22]. Whether IFN- entails APC demise
r inactivation remains to be determined. Thus, al-
hough our mechanistic understanding remains in-
omplete, the dominant paradigm holds that CTLs
xert immunodomination by physically or functionally
mpairing the ability of APCs to present antigen,
hereby preventing priming against nondominant
pitopes [3,19,20]. Restricting the duration of antigen
resentation through APC physical or functional de-
etion provides an efﬁcient feedback mechanism with
ervasive consequences on the size, diversity, and du-
ation of CD8 T-cell responses [20]. Of note, the
bilities to exert and to resist immunodomination are
irectly related [11,13,23]. Thus, whereas cell-surface
xpression of the H7a minor histocompatibility anti-
en (MiHA) prevents priming against many MiHAs
resent on C57BL/6 cells, H7a-speciﬁc CTLs consis-
ently resist immunodomination by CTLs speciﬁc for
myriad of other MiHAs [13,16,23]. In contrast, the
Y MiHA elicits a CTL response only when pre-
ented alone. Although expression of other MiHAs
oes not modify expression of HY at the APC surface,
t totally abrogates the HY-speciﬁc CTL response
16,24]. Two fundamental and related inferences can
e drawn from these data. First, compared with other
TLs, those that exert immunodomination lead to
ore rapid APC deletion or inactivation. Second, that
wift termination of antigen presentation affects only
TLs speciﬁc for nondominant epitopes means that
hese CTLs require a longer duration of antigen pre-
entation than CTLs speciﬁc for dominant epitopes.
To elucidate the mechanisms of immunodomina-
ion, we performed a comprehensive set of studies on
D8 T cells speciﬁc for 2 models of antigens pre-
ented by H2Db: H7a (also known as B6dom1) and HY.
e thought that selecting these antigens would max-mize the sensitivity of our studies because, as men- H
B&MTioned previously, H7a and HY lie at opposite ends of
he immunodomination scale (that is, in their ability
o exert and resist immunodomination). Thus, when
resented alone, these antigens elicit CTL re-
ponses of similar amplitude, but H7a totally abro-
ates the response to HY when both antigens are
resented on the same APC [13,16]. This cannot be
xplained by differences in epitope stability, because
he half-lives of H7a/Db and HY/Db complexes are
imilar (8 hours) [23]. We focused herein on the
ollowing parameters: T-cell frequency in the preim-
une repertoire, T-cell receptor (TCR) diversity of
ntigen-reactive T cells, and T-cell interactions with
elf as well as with their cognate antigen. We report
hat the salient difference between CTLs speciﬁc for
7a and HY is that the former display much more
apid tetramer binding than the latter. Our data allow
or the development of a model in which the result of
ross-competition between CTLs speciﬁc for differ-
nt epitopes depends on the TCR:epitope on-rate of
ompetitors. This paradigm makes distinct and test-
ble predictions and integrates numerous reports con-
erning immunodomination.
ATERIALS AND METHODS
ice
C57BL/10Snj (B10), B10.C-H7b(47N)/SN (B10.H7b),
nd BALB/c mice were obtained from the Jackson
aboratory (Bar Harbor, ME). Mice were bred in the
uy-Bernier Research Center and maintained in spe-
iﬁc pathogen–free conditions according to the stan-
ards of the Canadian Council on Animal Care.
eptides
H7a (KAPDNRETL) and HY(Uty) (WMHHN-
DLI) peptides were synthesized by the Sheldon Bio-
echnology Center (Montreal, QC, Canada). Purity,
s determined by reverse-phase high-performance liq-
id chromatography and mass spectrometric analysis,
as greater than 97%.
ntibodies, Major Histocompatibility Complex
lass I Tetramers, and Flow Cytometry
Cell suspensions were stained with the following anti-
odies fromBDBiosciences Pharmingen (SanDiego, CA):
nti-CD8 (53-6.7), anti-TCR (H57-597), anti-V2
B20.1), anti-V3.2 (RR3-16), anti-V8.3 (B21.14), an-
i-V11.1/11.2b,d (RR8-1), anti-V2 (B20.6), anti-V3
KJ25), anti-V4 (KT4), anti-V5.1/5.2 (MR9-4), anti-
6 (RR4-7), anti-V7 (TCR310), anti-V8.1/8.2
MR5-2), anti-V9 (MR10-2), anti-V10b (B21.5), anti-
11 (RR3-15), anti-V12 (MR11-1), anti-V13
MR12-3), anti-V14 (14-2), anti-V17a (KJ23), anti-
2Db (28-14-8), and anti-CD5 (53-7.3). H7a/Db and
7b/Db tetramers were obtained from the Canadian
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2etwork for Vaccines and Immunotherapies Tetramer
ore Facility (Montreal, QC, Canada). HY(Uty)/D
b and
CMV gp33-41/Db tetramers were obtained from
eckman Coulter Immunomics (San Diego, CA). All
cquisitions were made on a FACSCalibur ﬂow cytom-
ter by using CellQuest software (BD Biosciences,
ountain View, CA).
etramer Binding Assays
Tetramer association assays (TCR-peptide:major
istocompatibility complex [pepMHC] on-rate) were
erformed as described previously [25,26]. Anti-H7a
nd -HY CTLs were obtained after priming of
10.H7b female mice by intraperitoneal injection of
 107 splenocytes from B10 and B10.H7b male
onors, respectively. On day 14 after priming, spleen
ells were stained by anti-CD8 antibody and graded
oncentrations of tetramers ranging from 3.5 to 270
mol/L. After incubation, cells were washed exten-
ively, ﬁxed in 1% paraformaldehyde, stained on ice
or 45 minutes, and analyzed by ﬂow cytometry. Tet-
amer decay assays (TCR-pepMHC off-rate) were
erformed as described [26,27]. Brieﬂy, in vivo–
rimed spleen cells were stained with saturating con-
entrations of anti-CD8 antibody and H7a/Db or
Y(Uty)/D
b tetramers for 45 minutes. Cells were
ashed, cultured for various periods of time at 25°C in
he presence of saturating amounts of puriﬁed anti-Db
ntibody, ﬁxed in 1% paraformaldehyde, and analyzed
y ﬂow cytometry. The tetramer-speciﬁc total ﬂuo-
escence was determined according to Savage et al.,
27] normalized to the percentage of the total ﬂuores-
ence at the initial time point, and plotted on a loga-
ithmic scale.
ingle-Cell Reverse Transcriptase-Polymerase
hain Reaction and TCR Sequencing
B10.H7b mice were primed by intraperitoneal in-
ection of 2  107 B10 spleen cells. On day 14 after
riming, single immune (CD8V8V8H7a/Db
etramer) T cells were sorted directly in a 96-well
olymerase chain reaction (PCR) plate containing 20
L of complementary DNA (cDNA) reaction mix by
sing a FACSVantage SE with Diva Option (BD Bio-
ciences, San Jose, CA). The cDNA reaction mix con-
ained 1 cDNA buffer, 1.0 L of Sensiscript Reverse
ranscriptase, 0.5 mmol/L each deoxynucleotide
riphosphate, 1 mol/L oligo-dT primers, and 10 U
ibonuclease inhibitor (Qiagen Inc., Mississauga,
NT, Canada). After sorting, plates were frozen,
hawed, and incubated at 37°C for 60 minutes to
erform the reverse-transcriptase reaction, followed
y 5 minutes at 93°C to stop the reverse-transcriptase
ctivity. The V8 or V8 transcripts were ampliﬁed
rom 2.5 L of cDNA by nested PCR in a 25-L
mpliﬁcation reaction with Taq polymerase (Invitro- I
62en, Burlington, ON, Canada), by using oligonucleo-
ides designed by Baker et al. [28] The ﬁrst-round
eaction was performed with the external primers:
8-ext (TGGGAACAAAACACATGGAGGC)/C-
xt (CTATAATTGCTCTCTTGTAGG) and V8-
xt (CTGTGATGCTGAACTGCACC)/C3=-ext
TCAACTGGACCACAGCCTCAG). The second
ound was performed with a 2.5-L aliquot from the
rst round with internal primers: V8-int (ATGTACT-
GTATCGGCAGGAC)/C100-int (AAGCCCCT-
GCCAAGCACAC) and V8-int (GCCACTCTC-
ATAAGAGCAG)/CR-int (TAGGTGGCGGTG-
TCTCTTTG). For each round, PCR conditions
ere 94°C for 3 minutes followed by 30 cycles of 94°C
or 30 seconds, 56°C for 30 seconds, and 72°C for 1
inute, followed by a ﬁnal extension cycle of 72°C for
0 minutes. PCR products were resolved on a 2%
garose gel, puriﬁed on QIAquick Gel extraction spin
olumns (Qiagen), and sequenced at the Analysis and
ynthesis Facility of Laval University (Quebec, QC,
anada).
imiting Dilution Assays of CTL Precursors
Limiting numbers of responder spleen cells from
nprimed animals were cultured in 96-well round-
ottomed plates with constant numbers (2.5  105) of
rradiated stimulator spleen cells pulsed with 20
mol/L H7a or HY(Uty) peptide for 40 minutes at
7°C. Cell cultures were made in Iscove medium with
etal bovine serum (10%), l-arginine (116 mg/L),
-asparagine (36 mg/L), l-glutamine (216 mg/L),
L-2 (20 U/mL), IL-4 (10 ng/mL), and IL-7 (10
g/mL). On day 7 and 14, 50% of the medium was
eplaced by fresh medium containing IL-2, IL-4,
L-7, and 20 mol/L of the respective peptide. Tet-
amer labeling was performed on day 21, and detec-
ion of tetramer-positive cells was performed as de-
cribed [29]. Brieﬂy, cells were washed and incubated
t room temperature for 30 minutes with speciﬁc and
rrelevant (LCMV gp33-41/Db) tetramers. The anal-
sis procedure is depicted in Figure 1A and was aimed
t gating out those among CD8 T cells that emit a
igher-than-background ﬂuorescence at 670 nm when
xcited at 488 nm (autoﬂuorescence) or those that
ind an irrelevant tetramer. According to Poisson sta-
istics, the tetramer-labeled clusters in the positive
icrocultures (less than 10% of the wells) each rep-
esent a single clone. Wells were scored positive when
he percentage of cells speciﬁcally labeled by tetram-
rs containing the peptide used for stimulation was
ore than 3 SD over mean results for negative con-
rols (ie, male cells stimulated by HY and B10 cells
timulated by H7a).
In some experiments, analyses of precursor fre-
uencies were performed on subsets of CD8 T cells.
n this case, unprimed spleen cells were depleted with
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Selection of Immunodominant Determinants
Bnti-pan B (B220) and anti-CD4 (L3T4) beads (Dynal
iotech, Brown Deer, WI) and stained with antibodies
gainst CD8 and CD5. The low, intermediate, and
igh CD5 subsets of CD8 T cells were sorted, and 5
04 CD8 T cells were cultured in 96-well round-
ottomed plates with 2.5  105 stimulator spleen cells
pulsed with 20 mol/L of peptide) and 1  105
utologous irradiated spleen cells as feeders.
ESULTS
he Diversity of the Repertoire of H7a-Specific
D8 T Cells Is Extremely Limited
Signiﬁcant insight into the bases of immunodomi-
ation may be gained from studies on MiHAs because,
ith their tens of thousands of proteins, mammalian
ells represent the most complex entity to which
TLs can be confronted in the antigenic universe
30]. Studies based on 4 molecularly deﬁned BALB.B
iHAs recognized by C57BL/6 cells provided evi-
ence that the diversity of the CD8 T-cell TCR reper-
oire may be correlated with immunodominance. Thus,
ALB.B H28 and H60 MiHAs are immunodominant,
igure 1. Anti-H7a and anti-HY CD8 T-cell precursors exhibit
imilar frequencies and CD5 expression levels in naive B10.H7b
ice. A, Procedure for the analysis of lymphocytes labeled by H7a
r HY tetramers. Autoﬂuorescent cells and those that bind an
rrelevant tetramer are gated out. B, One hundred eighty-three
icrocultures were set up with splenocyte suspension adjusted to
 104 CD8 T cells per well. These cells were stimulated with HY
r H7a as described in Materials and Methods. Plots show tetramer
abeling of CD8 T cells in the positive anti-H7a (top row) and
nti-HY (bottom row) wells. C, Gating procedure used to separate
D5lo, CD5int, and CD5hi CD8 T-cell subsets. Cells from these
subsets were plated in different wells. D, Frequency of positive
icrocultures obtained from CD5lo, CD5int, and CD5hi CD8
cells. Culture conditions and cell gating procedures were similar
o those used in the estimation of precursor frequency (A and B).nd C57BL/6 responder mice carry null alleles [30-32]. l
B&MTn contrast, H13 and H47 are not immunodominant,
nd B6 mice share closely matched allelic analogs with
ALB.B mice [33-35]. It was therefore proposed that
n the absence of a self analog peptide, the complete
ack of negative selection should provide a more di-
ersiﬁed peripheral repertoire [32]. However, recent
iochemical deﬁnition of the model immunodominant
7a MiHA (KAPDNRETL, corresponding to amino
cids 770 to 778 of the SIMP/STT3-B protein) and its
llelic product (H7b: KAPDNRDTL) appears at face
alue difﬁcult to reconcile with this paradigm [36].
ecause the 2 allelic H7 MiHAs differ by a single
ethylene group, it is difﬁcult to imagine how they
ight elicit diversiﬁed arrays of TCR clonotypes. We
herefore deemed it important to directly assess the
iversity of the anti-H7a TCR repertoire.
As a prelude to detailed studies of the T-cell rep-
rtoire, it was essential to validate the speciﬁcity of the
7a/Db tetramers used to identify and isolate H7a-
eactive CD8 T cells. Splenocytes from B10.H7b mice
rimed against B10 cells and B10 mice primed against
10.H7b cells were stained with H7a/Db and H7b/Db
etramers. Even though H7a and H7b differ by a single
H2 group [36], T cells bound only the allelic prod-
ct against which they were primed and not the self
llelic product (Figure 2). Thus, H7a/Db tetramers
sed in this work showed exquisite speciﬁcity.
B10.H7b mice were primed with 2  107 B10
ells, and their splenocytes were harvested on day 14,
hen approximately 5% of CD8 T cells were H7a
peciﬁc [16]. H7a tetramer CD8 T cells were stained
ith a panel of 14 anti-V and 4 anti-V antibodies.
he TCR V repertoire of anti–anti-H7a T cells was
ramatically skewed because, in most mice (7 of 8),
etramer CD8 T cells used a single V element, in
ost cases V8 (Figure 3). Although the panel of
vailable anti-V antibodies is relatively restricted,
ur data strongly suggest that TCR V use is also
kewed because in each mouse no more than 1 V
lement was detected on tetramer CD8 T cells.
To analyze more precisely the diversity of the
7a-speciﬁc repertoire, we focused on tetramer
D8 T cells bearing the TCR V and TCR V
lements most frequently detected in our ﬂow cytom-
try analyses: V8 and V8. The third complemen-
arity-determining regions (CDR3) of the TCR and
chains have a primary role in recognition of the
HC-bound peptide antigen and are thus responsible
or most of the speciﬁcity of TCR interactions. Sin-
le-cell PCR can estimate T-cell frequency accu-
ately, because it is not affected by skewed PCR am-
liﬁcation or different TCR messenger RNA
xpressions in individual T cells [37]. Thus, our ex-
erimental strategy involved single-cell sorting of tet-
amer/V8/V8 CD8 T cells, reverse transcrip-
ase-PCR ampliﬁcation, and sequencing of CDR3
oops of the TCR and  chains [28,38]. These single-
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2ell analyses were performed in 4 mice in which more
han 80% of tetramer CD8 T cells were stained by
nti-V8 and -V8 antibodies. CDR3 lengths were
esignated from the amino acid sequences, whereas
-element use was determined after comparison with
nown genomic sequences [39-42]. Analysis of 65
CR transcripts from 4 mice showed that the diver-
ity of the TCR chains was strikingly limited, and
onserved features were clearly identiﬁed (Table 1).
ractically all TCR chains from sorted tetramer/
8/V8 CD8 T cells used V8.1 and J2.1 seg-
ents. In 94% of the cases (61/65), the CDR3 re-
ion had a length of 12 amino acids with conserved
harged residues: aspartic (D) or glutamic (E) acid at
2, arginine (R) at P3, and glutamic acid (E) at P11.
he TCR chains showed low diversity in each indi-
idual mouse and were remarkably similar among
ice. Overall, 94% of the CDR3 segments from the
mice harbored the following 12–amino acid consen-
us sequence: S(D/E)R(T/A)GGXNYAEQ. Analysis
f 47 TCR transcripts from the same tetramer/
8/V8 CD8 T-cell samples conﬁrmed the lim-
ted diversity of the H7a-speciﬁc repertoire (Table 1).
wo types of dominant TCR chains were found:
8.3-S(G/A)SSNTNKV-J27 in 2 mice and V8.3-
TGGYKV-J10 in the other 2. We therefore con-
lude that the H7a-speciﬁc CD8 T-cell repertoire
arvested at the time of primary response shows
ighly restricted TCR diversity.
nti-H7a and -HY CD8 T-Cell Precursors Have
imilar Frequencies
Because the role of precursor T-cell frequency in
mmunodomination is controversial [5,11,43,44], we
eemed it necessary to assess the frequency of H7a-
nd HY-speciﬁc CD8 T cells in naive mice. The
requency of antigen-speciﬁc CD8 T cells in naive
igure 2. H7a (KAPDNRETL) and its allelic peptide H7b (KAP-
NRDTL) are not cross-reactive at the TCR level. Splenocytes
rom B10.H7b mice primed against B10 cells (anti-H7a) and from
10 mice primed against B10.H7b (anti-H7b) were stained with H7a
nd H7b tetramers.ice is typically approximately 105 to 106 and is H
64hus below the detection limit of standard tetramer-
taining methods [43,45]. Indeed, the proportion of
pleen CD8 T cells stained by H7a/Db tetramers was
ot higher in B10.H7b mice than in our negative
ontrols: H7a-positive mice (B10) and H2Db-negative
ice (BALB/c; data not shown). Likewise, the propor-
ion of CD8 T cells stained by HY/Db tetramers was
imilar in male and female B10.H7b mice (data not
hown). Thus, the frequency of H7a- and HY-speciﬁc
cells is less than 103. To evaluate precursor fre-
uencies, we therefore used a very sensitive method
eveloped by Karanikas et al [29]. This method in-
olves in vitro culture of T cells with peptide-coated
timulating cells under limiting dilution conditions in
ytokine-supplemented milieu. On day 21, T cells
rom B10.H7b female mice stimulated with HY- or
7a-coated cells were labeled with anti-CD8 antibody
nd the cognate tetramer. Cells that were autoﬂuores-
ent or that were labeled by an irrelevant tetramer
LCMV gp33-41/Db) were gated out (Figure 1A). As
result of the limiting dilution, each positive micro-
ultures represents a single clone. Because in vitro
eptide-driven CTL expansion systems may allow ex-
ansion of CTLs exhibiting relatively low afﬁnity for
igure 3. H7a-tetramer CD8 T cells use mainly TCR V8 and
8 chains. Splenocytes from B10.H7b mice primed with B10
plenocytes were stained on day 14 with antibodies against various
CR V and V chains. Nonimmune B10.H7b mice were used as
ontrols. Results from nonimmune B10.H7b control mice (n  5)
re presented as the mean  SD. Results from mice primed against
7a are presented individually for the 8 mice tested.
Table 1. Amino Acid and Nucleotide Sequences of the TCR and  Chain Hypervariable Regions of H7a Tetramer/V8/V8/CD8 T Cells*
Mouse
TCR
V Gene Length
CDR3 Sequence
TCR D/J Occurrence1 2 3 4 5 6 7 8 9 10 11 12
Mouse 1 8.1 C A S 12 S D R T G G A N Y A E Q F F G D2.1/J 2.1 7/14
TGT GCC AGC AGT GAC AGG ACT GGG GGG GCA AAC TAT GCT GAG CAG TTC TTC GGA
8.1 C A S 12 S D R A G G V N Y A E Q F F G D2.1/J 2.1 5/14
TGT GCC AGC AGT GAT CGG CCT GGG GGG GIT AAC TAT GCT GAG CAG TTC TTC GGA
8.1 C A S 12 S D R T G G V N Y A E Q F F G D2.1/J2.1 1/14
TGT GCC AGC AGT GAT CGT ACT GGG GGG GTG AAC TAT GCT GAG CAG TTC TTC GGA
8.1 C A S 8 S E R T S Y E Q Y F G D2.1/J 2.6 1/14
TGT GCC AGC AGT GAG AGG ACT TCC TAT GAA CAG TAC TTC GGA
Mouse 2 8.1 C A S 12 S D R T G G V N Y A E Q F F G D2.1/J 2.1 12/14
TGT GCC AGC AGT GAT CGT ACT GGG GGG GTG AAC TAT GCT GAG CAG TTC TTC GGA
8.1 C A S 12 S D T T G G E Y Y A E Q F F G D1.1/J 2.1 1/14
TGT GCC AGC AGT GAT ACT ACA GGG GGG GAA TAC TAT GCT GAG CAG TTC TTC GGA
8.3 C A S 12 S G D G G G Y N Y A E Q F F G D2.1/J 2.1 1/14
TGT GCC AGC AGT GAT CGT ACT GGG GGG GTG AAC TAT GCT GAG CAG TTC TTC GGA
Mouse 3 8.1 C A S 12 S E R T G G P N Y A E Q F F G D2.1/J 2.1 16/16
TGT GCC AGC AGT GAG AGG ACT GGG GGG GCA AAC TAT GCT GAG CAG TTC TTC GGA
Mouse 4 8.1 C A S 12 S E R T G G P N Y A E Q F F G D2.1/J 2.1 18/21
TGT GCC AGC AGT GAA CGG ACT GGG GGG CCT AAC TAT GCT GAG CAG TTC TTC GGA
8.1 C A S 11 R P S G G A N Y A E Q F F G D2.1/J 2.1 3/21
TGT GCC AGC AGA CCC TCT GGG GGG GCT AAC TAT GCT GAG CAG TTC TTC GGA
Consensus  CDR3 S D E R T A G G X N Y A E Q
AGT GAT A CGT A GCT GGG GGG AAC TAT GCT GAG CAG
Mouse
TCR
V Gene Length
CDR3 Sequence
TCR J Occurrence1 2 3 4 5 6 7 8 9
Mouse 1 8.3 C A L 9 S G S S N T N K V V F G 27 5/6
TGT GCT CTG AGT CGA TCT TCC AAT ACC AAC AAA GTC GTC TTT GGA
8.3 C A L 4 S D R I F F G 24 1/6
TGT GCT CTG AGC GAC AGA ATC TTC TTT GGT
Mouse 2 8.3 C A L 9 S A S S N T N K V V F G 27 10/10
TGT GCT CTG AGT GCC TCT TCC AAT ACC AAC AAA GTC GTC TTT GGA
Mouse 3 8.3 C A L 7 G T G G Y K V V F G 10 13/13
TGT GCT CTG GGG ACT GGA GGC TAT AAA GTG GTC TTT GGA
Mouse 4 8.3 C A L 7 G T G G Y K V V F G 10 18/18
TGT GCT CTG GGG ACT GGA GCC TAT AAA GTG GTC TTT GGA
*Lymphocytes were obtained from the spleen of individual B10.H7b mice 14 days after priming against H7a cells and were then processed for single-cell CDR3 analysis as described in Materials and
Methods.
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2he target peptide, further studies are needed to eval-
ate the functional avidity of our in vitro–grown
-cell clones. Nevertheless, under these conditions,
he frequencies of HY- and H7a-speciﬁc CD8 T cells
n nonimmunized B10.H7b female mice were approx-
mately 1.4  106 and 1.7  106, respectively (Fig-
re 1B). These frequencies are consistent with those
f other antigen-speciﬁc cells [43,45] and show that
he immunodomination of H7a over HY cannot be
scribed to a higher frequency of H7a-speciﬁc T cells
n the preimmune repertoire.
ack of Correlation between Immunodominance
nd Levels of CD5 Expression on Preimmune
Cells
Models proposed so far have posited a priori that
mmunodomination should be regulated by only 2
actors: T-cell precursor frequency and TCR interac-
ions with the cognate antigen. We hypothesized that
third factor might play a key role: CTL interactions
ith self pepMHC as opposed as to foreign antigens.
his idea stems from the demonstration that TCR
ngagement by self pepMHC actively sustains the
aive T cells in an optimal state of sensitivity by
ustaining partial phosphorylation of TCR	 and TCR
lustering. The strength of TCR interactions with self
epMHC differs among TCR clonotypes and can be
stimated by using 2 parameters: the level of TCR	
hain phosphorylation and expression of CD5 levels
46-49]. There is no means to assess TCR	 chain
hosphorylation of T cells speciﬁc for nominal anti-
en (eg, H7a or HY) in the preimmune repertoire of
on–TCR-transgenic wild-type mice. Nevertheless,
e reasoned that we should be able to determine
hether T cells speciﬁc for a given antigen are en-
iched among CD5lo or CD5hi T-cell subsets by esti-
ating the frequency of antigen-speciﬁc T cells in
orted populations of CD8 T cells expressing different
evels of CD5. We therefore used CD5 expression on
D8 T cells as a surrogate marker for the strength of
CR interactions with self pepMHC.
Spleen CD8 T cells from B10.H7b mice were elec-
ronically sorted into 3 subsets: CD5lo, CD5int, and
D5hi T cells (Figure 1C). Sorted cells were cultured
ith peptide-coated stimulating cells under limiting con-
itions, as in previously described experiments on the
stimation of CD8 T-cell precursor frequencies. The
roportion of positive cultures was 7 of 131 for H7a-
peciﬁc T cells and 11 of 222 for HY-speciﬁc T cells.
he salient ﬁnding is that the distribution of positive
ells among CD5lo, CD5int, and CD5hi T cells was
imilar for H7a and HY (Figure 1D). In both cases,
ntigen-speciﬁc CD8 T-cell precursors were mainly
ound in the CD5lo/int as opposed to the CD5hi subset
Figure 1). These data unveil no relation between im-
unodominance and CD5 expression. They thus pro-
ide indirect evidence against the idea that the strength m
66f TCR interactions with self pepMHC shapes the im-
unodomination hierarchy.
inetics of TCR:Epitope Interactions
T-cell structural avidity, determined by the direct
inding afﬁnities of multiple cell-bound TCR mole-
ules for pepMHC, is most commonly measured by
taining with pepMHC multimers [26,27,50-52]. The
esults of tetramer association (on-rate) and tetramer
ecay (off-rate) assays closely correspond to the Kon
nd Koff rates, respectively, of the interaction between
he soluble TCR and immobilized pepMHC [25,27].
hus, we next examined the structural avidity of in-
eractions between H7a- and HY-speciﬁc T cells and
heir speciﬁc ligand on day 14 after in vivo priming,
hat is, at the time of primary response. In contrast
ith other studies [53], our experiments were con-
ucted on freshly harvested spleen CD8 T cells with-
ut in vitro restimulation because in vitro culture may
avor preferential expansion of selected T-cell clono-
ypes. Splenocytes from each mouse were tested indi-
idually (not pooled), and a single batch of H7a/Db
nd HY/Db tetramers was used in these experiments.
We ﬁrst compared the tetramer staining decay
TCR:pepMHC off-rate) of H7a- and HY-speciﬁc
D8 T cells. Of note, anti-H7a and -HY tetramer
ells expressed equivalent levels of CD8 and TCR
Figure 4A). Noticeably, the mean tetramer decay rate
as not slower for H7a-speciﬁc relative to HY-speciﬁc
cells (Figure 4B and C). Consistent with a previous
eport [27], the level of animal-to-animal variation
the standard variation of decay plots) after primary
mmunization was signiﬁcant in each group. A key
oint is that the TCR:pepMHC off-rate showed no
ess intragroup variation for H7a-speciﬁc relative to
Y-speciﬁc T cells (Figure 4C). This means that
here was no enrichment for T cells with a slower
CR dissociation rate among anti-H7a compared
ith anti-HY T cells.
To estimate the TCR:pepMHC on-rate, T cells
arvested on day 14 after primary immunization
ere incubated with increasing concentrations of
etramers. H7a-speciﬁc T cells showed a much
igher tetramer binding rate than HY-speciﬁc T
ells (Figure 4D). Thus, tetramer concentrations
equired to reach 50% and 75% normalized ﬂuo-
escence were 3.0 and 7.5 nmol/L for anti-H7a T
ells versus 30.0 and 130.0 nmol/L for anti-HY T
ells (P 
 .001; Student t test). Thus, at the time of
rimary response, the TCR:pepMHC off-rate is
imilar for anti-H7a and -HY T cells, whereas the
n-rate is much more rapid in the case of H7a-
peciﬁc T cells.
We next sought to determine whether a more
apid TCR:pepMHC on-rate would correlate with a
ore rapid T-cell expansion. We therefore immu-
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Bized B10.H7b female mice with B10 or B10.H7b
ale cells to evaluate the kinetics of CD8 T-cell
esponses against H7a and HY, respectively. The
umber of tetramer CD8 T cells was measured from
igure 4. TCR:pepMHC dissociation and association rates for ()
7a- and (□) HY-speciﬁc CD8 T cells harvested at the time of
rimary response (day 14 after antigen priming). A, CD8 T cells
abeled with H7a and HY tetramers were stained with antibody
gainst CD8 and TCR. B, One representative example of an
7a-tetramer decay plot series. C, Decay plot of the natural loga-
ithm of the normalized total ﬂuorescence versus time (after the
ddition of anti-Db monoclonal antibody) for primed splenocytes
tained with H7a or HY tetramers. The rate of tetramer decay was
imilar for cells labeled with H7a and HY tetramers (P  .427). D,
o evaluate the TCR:pepMHC association rate, day 14 splenocytes
ere incubated with graded concentrations of the relevant tetramer.
and D, Each point represents the mean of 5 to 10 mice tested.ay 5 to 30. The maximum response was deﬁned as t
B&MT00%, and other responses were plotted as a fraction
f that maximum response. The key ﬁnding was that
he maximum response was reached signiﬁcantly ear-
ier for H7a-speciﬁc T cells than for HY-speciﬁc
cells (Figure 5). In addition, contraction of the
nti-HY CD8 T-cell population was more rapid than
hat of anti-H7a CD8 T cells (cf day 25 in Figure 5).
hese data support the idea that a more rapid TCR:
epMHC on-rate leads to a faster and more pro-
onged CD8 T-cell expansion.
ISCUSSION
he Diversity of the TCR Repertoire
The TCR repertoire selected by discrete pep-
HC ranges from oligoclonal to extremely diverse
43,54-57]. Our work shows that the TCR repertoire
merging during the primary response to the immu-
odominant H7a antigen is oligoclonal. Two points
an be made from the very limited heterogeneity of
he anti-H7a repertoire. First, the potential for immu-
odominance is not directly related to TCR diversity.
econd, because the product of the H7b allele differs
rom H7a by a single methylene group, our data sup-
ort the concept that the degree of homology between
he cognate antigen and self peptides has a dominant
nﬂuence on the diversity of the TCR repertoire [58].
he fact that anti-H7a CD8 T cells represent approx-
mately 5% of the peripheral T-cell population 14
ays after antigen encounter [16], but derive from a
mall number of clones (Figure 3 and Table 1), indi-
ates that these clones are ampliﬁed with remarkable
fﬁciency during the primary response.
The relation between TCR diversity and the efﬁ-
acy of immune responses is complex. High TCR
iversity increases the likelihood that the repertoire
igure 5. Kinetics of CD8 T-cell responses against H7a and HY.
10.H7b female mice were immunized with B10 or B10.H7b male
ells to evaluate the kinetics of CD8 T-cell responses against H7a
nd HY, respectively. The number of tetramer CD8 T cells in the
pleen was measured on day 5, 10, 15, 20, 25, and 30. The maximum
esponse was deﬁned as 100%, and other responses were plotted as
fraction of that maximum response. There were 4 to 7 mice perime point. *P 
 .05; Student t test.
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2ontains T cells with optimal avidity to recognize
mmunodominant epitopes and that TCR clonotypes
peciﬁc for mutated or secondary epitopes are avail-
ble to prevent escape by mutation [59]. A greater
CR diversity is therefore considered to be beneﬁcial
o the host. Remarkably, although we show herein
hat H7a-speciﬁc CD8 T cells display very limited
CR diversity, these T cells are extremely effective in
radicating H7a-positive neoplastic cells [60]. This
hould not be construed as a deterrent to the putative
mportance of a diversiﬁed T-cell repertoire in gen-
ral. This apparent paradox rather suggests that in the
resence of T cells speciﬁc for immunodominant an-
igens, TCR diversity is dispensable as long as the
arget epitope shows a low mutation rate. Indeed, in
itro immunoselection studies with anti-H7a CTLs
ave shown that H7a loss was an exceedingly rare
vent [61]. In line with this, the structure of SIMP/
TT3-B, the source protein of H7a, is highly con-
erved among species and is nearly invariant among
uman individuals and inbred strains of mice [36,62].
corollary to data emerging from analyses of
nti-H7a CTL responses is that targeting epitopes
ith a low mutation frequency may confer an advan-
age for T-cell immunotherapy.
he Frequency of Antigen-Specific CD8 T Cells in
he Preimmune Repertoire and Their Interactions
ith Self
Because immunodomination results from compe-
ition for APC resources, it sounds intuitively plausi-
le that high antigen-speciﬁc T-cell precursor fre-
uency in the preimmune repertoire might confer a
ompetitive advantage [44]. Considering the attrac-
iveness of this concept, differential precursor fre-
uencies are commonly invoked as putative contribu-
ory factors to immunodomination, although few
irect assessments of antigen-speciﬁc precursor fre-
uencies have been made in nonimmune animals.
learly, even though H7a and HY lie at opposite ends
n the immunodomination hierarchy, H7a-speciﬁc T
ells are not more abundant than HY-speciﬁc T cells
n naive mice. Even though H7a is at the summit of
he immunodomination hierarchy on C57BL/6 cells,
e argue that the unremarkable frequency (105 to
06) of anti-H7a T cells in the nonimmune reper-
oire is not idiosyncratic. Indeed, similar precursor
requencies have been observed with T cells speciﬁc
or immunodominant viral epitopes from LCMV and
pstein-Barr virus [5,45]. Furthermore, 2 studies
howed that injection of very large numbers of mem-
ry CD8 T cells speciﬁc for immunodominated anti-
en did not enable these T cells to compete more
uccessfully against T cells that recognized dominant
pitopes [11,32]. We therefore deduce that, except
erhaps in some extreme situations, CD8 T-cell pre- s
68ursor frequency does not impinge on immunodomi-
ation.
It has been proposed that one chief role of the
ackground TCR signals induced by self pepMHC is
o enhance sensitivity to foreign antigen [46,47]. We
herefore tested the novel idea that interactions with
elf pepMHC might enable some CD8 T cells to react
ore promptly than others to their cognate antigen
nd thereby exert immunodomination. Our data on
D5 levels at the surface of naive T cells, used as a
urrogate marker for the intensity of TCR tickling in
he periphery, provide indirect evidence against our
ypothesis.
CR:Epitope Interaction Kinetics
Data summarized in the Introduction lead us to
nfer that the crux of immunodomination is speed:
ompared with other CTLs, those that exert immu-
odomination are primed after a shorter duration of
ntigen presentation and swiftly generate effector
echanisms that entail prompt deletion or inactiva-
ion of APCs. This paradigm is supported by direct
vidence that the duration of antigen presentation
equired to prime naive T cells varies as a function of
-cell antigen speciﬁcity [20,63]. Furthermore, the
peed paradigm dovetails well with a recent report
hat the rapidity with which CD8 T cells initiate
FN- synthesis correlates with immunodominance
22]. Moreover, anti-H7a, but not anti-HY, CD8 T
ells rapidly eliminate APCs presenting their cognate
ntigen in vivo [19]. In line with the speed model, we
eport that the salient differences between anti-H7a
nd -HY CD8 T cells are that the former display a
uch more rapid TCR:pepMHC on-rate (Figure 4)
nd proliferate more rapidly after antigen priming
Figure 5). Our assumption that the TCR:pepMHC
n-rate decisively inﬂuences the swiftness of T-cell
riming is supported by elegant studies from Kalergis
t al [64]. When they examined the effects of point
utations in the CDR3 -chain of a Kb-restricted
CR, these authors found that in vitro T-cell activa-
ion was promoted in a mutant (G97A) that, compared
ith the wild-type TCR, displayed a more rapid on-
ate without prolongation of the off-rate. In contrast,
utants with longer TCR:pepMHC off-rates than the
ild-type TCR were less responsive, possibly because
f less effective TCR serial engagement [64].
One has to be cautious in extrapolating in vivo the
onsequences of discrepancies in the in vitro TCR:
epMHC on-rate among T cells with different anti-
en speciﬁcities. In vivo imaging of T-cell interactions
ith APCs in the lymph nodes has shown that the
ascade of events leading to T-cell priming occurs
ery rapidly. Initial signs of T-cell activation appear
uring the ﬁrst 8 hours after the APC encounter, and
ecretion of cytokines such as IL-2 and IFN- begins
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Buring the subsequent 12 hours [65]. Thus, given the
ast pace of initial interactions between T cells and
PCs, a quick TCR:pepMHC on-rate could confer
decisive advantage among T cells competing for
PC resources. As a corollary, immunodomination
hould not occur when competing CD8 T cells have
imilar TCR:pepMHC on-rates. This would explain
hat competition for APC resources does not mold
he repertoire of T-cell responses in some models
12,44].
Studies of T cells with other antigen speciﬁcities will
e needed to evaluate the generality of ourmodel, that is,
hether differences in the TCR:pepMHC on-rate are
ot only sufﬁcient but also necessary to explain immu-
odomination. One prediction of our model is that an
ntigen such as H7a should lose its ability to exert im-
unodomination over HY, for example, in mice whose
cells speciﬁc for the 2 antigens have similar TCR:
epMHC on-rates. Testing this prediction seems de-
anding but might be achieved by testing the immu-
odomination potential of TCR-transgenic T cells with
he same antigen speciﬁcity but different TCR:pep-
HC on-rates.
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